Drugs / [68Ga]VMT02
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04904120 Comparator | Mar 2021 → Sep 2022 | cutaneous melanoma, metastatic melanoma, mucosal melanoma, uveal melanoma | Perspective Therapeutics | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [68Ga]VMT02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04904120 ↗ |